Oireachtas Joint and Select Committees

Wednesday, 8 November 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion (Resumed)

9:00 am

Mr. John Hennessy:

Regarding price negotiations and confidentiality, our preference would be that it would not be done in that manner and that it would be more transparent and open as a public body. Obviously, companies feel that they have to operate in a price-confidential manner in the process and, as Mr. Flanagan said, those negotiations do become protracted on some occasions.

Comments

No comments

Log in or join to post a public comment.